Balaxi Pharmaceuticals Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 659.55 million compared to INR 827.85 million a year ago. Revenue was INR 649.47 million compared to INR 860.69 million a year ago.

Net loss was INR 413.43 million compared to net income of INR 141.47 million a year ago. Basic loss per share from continuing operations was INR 40.49 compared to basic earnings per share from continuing operations of INR 14.15 a year ago.